Headache and Migraine

>

The NeurologyLive® headache and migraine clinical focus page offers information, podcasts, videos, and news and interviews with physicians related to the care of patients with headache disorders such as chronic and episodic migraine, cluster headache, tension-type headache, and more. The page includes updates on the latest FDA actions, clinical guidelines, and study and clinical trial findings.

Latest News

Electronic Health Record Study Finds No Significant Cardiovascular Risk With Triptan Use for Migraine
Electronic Health Record Study Finds No Significant Cardiovascular Risk With Triptan Use for Migraine

August 16th 2025

A recent study reassured that triptans may be safe for migraine treatment, emphasizing the need for individualized assessments of cardiovascular risks.

Openwater’s LIFU Technology at MIT: A New Era for Consciousness and Neurological Care
Openwater’s LIFU Technology at MIT: A New Era for Consciousness and Neurological Care

August 7th 2025

FDA Approves Fremanezumab as First Anti-CGRP Preventive Therapy for Pediatric Episodic Migraine
FDA Approves Fremanezumab as First Anti-CGRP Preventive Therapy for Pediatric Episodic Migraine

August 6th 2025

NeurologyLive® Friday 5 — August 1, 2025
NeurologyLive® Friday 5 — August 1, 2025

August 1st 2025

NeurologyLive® Friday 5 — July 25, 2025
NeurologyLive® Friday 5 — July 25, 2025

July 25th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.